Related references
Note: Only part of the references are listed.Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: Suppression of NF-κB activation and MAPK signaling
Hyeong-Seon Lee et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-κB
Tsu-Tuan Wu et al.
CYTOKINE (2011)
Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-κB in macrophages
Dan Feng et al.
INFLAMMATION RESEARCH (2010)
Effect of Acute Poly(ADP-Ribose) Polymerase Inhibition by 3-AB on Blood-Brain Barrier Permeability and Edema Formation after Focal Traumatic Brain Injury in Rats
Thomas Lescot et al.
JOURNAL OF NEUROTRAUMA (2010)
Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
Flavio Moroni
CURRENT OPINION IN PHARMACOLOGY (2008)
Inflammation as a causative factor in the aetiology of Parkinson's disease
P. S. Whitton
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Effects of bacterial toxins on endothelial tight junction in vitro: A mechanism-based investigation
Ashok K. Singh et al.
TOXICOLOGY MECHANISMS AND METHODS (2007)
Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats
Gabor Lenzser et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Inmaculada Rite et al.
JOURNAL OF NEUROCHEMISTRY (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
DNA-independent PARP-1 activation by phosphorylated ERK2 increases EIk1 activity: A link to histone acetylation
Malka Cohen-Armon et al.
MOLECULAR CELL (2007)
Effects of chronic ethanol drinking on the bloodbrain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection
Ashok K. Singh et al.
ALCOHOL AND ALCOHOLISM (2007)
Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going?
Paul O. Hassa et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury
RA Mota et al.
LABORATORY INVESTIGATION (2005)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
R Kortekaas et al.
ANNALS OF NEUROLOGY (2005)
Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD(+) into a nuclear signal
MY Kim et al.
GENES & DEVELOPMENT (2005)
NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia
LY Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The therapeutic effects of PJ34 [N-(6-oxo-5,6dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation
GS Scott et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals
SH Koh et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice
B Veres et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Share Paper
